Acanda, A.M., Berlow, N.E., Fader, M., et al (2024). Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers.
Nature medicine,
Ahead of Print(), .
View in Pubmed
Shing Oh, K., Alloush, F., Fader, M., et al (2023). FANCC and PTCH1 gene loss in congenital infantile rhabdomyosarcoma with spindle cell features.
Pediatric blood & cancer,
70(4), e30083.
View in Pubmed
Ramirez, A.L., Townsend, A.N., ..., Fader, M.E., et al (2023). An Oncoplastic Approach to Primary Pediatric Pterygomaxillary Osteosarcoma.
The Cleft palate-craniofacial journal,
Ahead of Print(), .
View in Pubmed
Acanda de la Rocha, A.M., Fader, M., ..., Kathib, Z., et al (2021). Clinical Utility of Functional Precision Medicine in the Management of Recurrent/Relapsed Childhood Rhabdomyosarcoma.
JCO precision oncology,
5(), PO.20.00438.
View in Pubmed
Eidson, M., Wahlstrom, J., Beaulieu, A.M., Zaidi, B., Carsons, S.E., Crow, P.K., et al. (2011). Altered development of NKT cells, yo T cells, CD8 cells and NK cells in a PLZF deficient patient.
PLoS One,
6(9), e24441.
View in Pubmed
Kovalovsky, D., Alonzo, E.S., Uche, O.U., Eidson, M., Nichols, K.E., Sant’Angelo, D.B. (2010). PLZF induces the spontaneous acquisition of memory/effector functions in T cells independently of NKT cell-related signals.
Journal of Immunology,
184(12), 6746-6755.
View in Pubmed
Kovalovsky, D., Uche, O.U., Eladad, S., Hobbs, R.M., Yi, W., Alonzo, E., Chua, K., Eidson, M., Kim, H.J., et al. (2008). The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.
Nature Immunology,
9(9), 1055-1064.
View in Pubmed